Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis — van Lanen et al., Eur J Nutr 2021
Systematic review and meta-analysis — 12 controlled intervention studies (9 parallel, 3 crossover), 772 adults with IBS. Moderate evidence. Eur J Nutr 2021;60(6):3505–3522. DOI 10.1007/s00394-020-02473-0. Free full text in PubMed Central (PMC8354978) — open access, CC BY 4.0. Note: Trials were small, lasted 3 months at most and were hard to blind, with signs of publication bias; the review was funded by Unilever, where the authors worked.
- What It Found
- Pooled 12 controlled studies (772 adults with IBS) comparing a low-FODMAP diet with other diets. The low-FODMAP diet reduced overall IBS symptom severity (standardised mean difference −0.66, 95% CI −0.88 to −0.44), lowered the IBS Symptom Severity Score by about 45 points in the studies that used it, and improved IBS-specific quality of life (mean difference 4.93 points, 95% CI 1.77 to 8.08).
- Why It Matters Here
- Backs up the low-FODMAP diet taught by the FODMAP-trained dietitians in chapter 15 (Monash University and King's College London directories) and the national dietitian finders there; most relevant to adults with IBS thinking about a supervised low-FODMAP diet.
Systematic review and meta-analysis — 12 controlled intervention studies (9 parallel, 3 crossover), 772 adults with IBS. Moderate evidence. Eur J Nutr 2021;60(6):3505–3522. DOI 10.1007/s00394-020-02473-0. Free full text in PubMed Central (PMC8354978) — open access, CC BY 4.0. Note: Trials were small, lasted 3 months at most and were hard to blind, with signs of publication bias; the review was funded by Unilever, where the authors worked.